Stemedica
  • About Us
    • Company Overview
    • Board of Directors
    • Management Team
  • Technology
    • Manufacturing
    • Our Progenitor Cells
    • Intellectual Property
  • Clinical
    • Clinical Pipeline
    • Clinical Trial Activities
      • Ischemic Stroke
      • Alzheimer’s Disease
    • R&D
  • Media
    • Press Releases
    • Publications
  • Contact
Select Page

Stemedica Awarded US Patent for Transgenic Therapeutic Stem Cells

by stemedica admin | Aug 13, 2015 | Intellectual Property

Stemedica Cell Technologies Inc., a leading manufacturer of adult, allogeneic stem cells and stem cell factors, received United States Patent No. 9080184 entitled “Transgenic Therapeutic Stem Cells and Methods for Their Use and Manufacture.” The patent issued on July...

Stemedica Earns US Patent for Cellular Scaffold Enhanced by Stem Cell Factors

by stemedica admin | Jun 9, 2015 | Intellectual Property

Stemedica Cell Technologies Inc., a leading manufacturer of adult, allogeneic stem cells and stem cell factors, received a new patent from the U.S. Patent & Trademark Office, US8709081 entitled “Cellular Scaffold.” This patent, coupled with the US8105380 patent...

Stemedica Issued US Patent Method for Identifying Neuripotent Cells

by stemedica admin | Feb 18, 2015 | Intellectual Property

Stemedica Cell Technologies, Inc., a leading manufacturer of adult allogeneic stem cells and stem cell factors, announced today that the Company has been issued Patent No. US 8,642,286 B2 entitled, Methods for Identifying Neuripotent Cells by the United States Patent...

Categories

  • Clinical Trials
  • Company Initiatives
  • Intellectual Property
  • Manufacturing
  • Partnerships
  • Publications
  • Subsidiaries

Copyright © 2007-2020 Stemedica Cell Technologies, Inc. All rights reserved.
6350 Nancy Ridge Drive, Suite 106, San Diego CA 92121 +1 858 658 0910

Privacy Policy